FOSAVANCE comprimés hebdomadaires 70/2800 4 pce

7680573860015 CH-57386 M05BB03 07.99.0.

Reimbursement limitations:

FOSAVANCE

Pour le traitement de l'ostéoporose documentée.

FOSAVANCE comprimés hebdomadaires 70/2800 4 pce
FOSAVANCE comprimés hebdomadaires 70/2800 4 pce
FOSAVANCE comprimés hebdomadaires 70/2800 4 pce
1 / 3
google

Details

Product number
5738601
CPT
-
Packaging group
4
Unit
Tablette(n)
Composition
acidum alendronicum 70 mg ut natrii alendronas trihydricus, cholecalciferolum 70 µg corresp. 2800 U.I., triglycerida media, gelatina, saccharum 8 mg, amylum modificatum, E 321, aluminii natrii silicas, lactosum 62.32 mg, cellulosum microcristallinum, silica colloidalis anhydrica, carmellosum natricum conexum, magnesii stearas pro compresso corresp. natrium 6.52 mg.

Articles (1)

Fosavance 70/2800, Wochentabletten
Wochentabletten
4
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
16/01/2024
Patient information leaflet
Français
16/01/2024
Patient information leaflet
Italien
16/01/2024
Professional SmPC
Allemand
16/01/2024
Professional SmPC
Français
16/01/2024
Professional SmPC
Italien
16/01/2024

Detailed composition

Substance Quantity Type Category
(N/A)
70.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
70.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
8.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance ANTOX
(N/A)
- Substance HNIDK
(N/A)
62.32 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
6.52 MG Substance HBESI

Authorization holder

Organon GmbH

6006 Luzern

Authorization information

Swissmedic authorization number
57386
Drug name
Fosavance, Wochentabletten
Galenic form
TAB
ATC Code
M05BB03
Authorization status
Z
Dispensation category
B
First authorization
30/11/2005
Authorization expiration date
31/12/9999
IT number
07.99.0.
Domain
Human medicine
Field of application
Osteoporose

Packaging details

Description (FR)
FOSAVANCE comprimés hebdomadaires 70/2800 4 pce
Description (DE)
FOSAVANCE Wochentabletten 70/2800 4 Stk
Market launch
30/11/2005
Narcotic (BTM)
No

Other packaging sizes

FOSAVANCE comprimés hebdomadaires 70/2800 12 pce
12 TABL
GTIN: 7680573860039
View
FOSAVANCE comprimés hebdomadaires 70/5600 4 pce
4 TABL
GTIN: 7680573860046
View
FOSAVANCE comprimés hebdomadaires 70/5600 12 pce
12 TABL
GTIN: 7680573860053
View